我們已在上線！進一步了解

MMTec

MTC

市值 US$6.04億

6.07 USD

+0.74

13.88%

收盤時已更新 10月16日下午4:00 EDT

盤前交易

盤後交易

5.95

-0.12

1.98%

1天

13.88%

5天

25.41%

1個月

16.06%

3個月

144.76%

6個月

1%

今年迄今

75.43%

1年

559.78%

5年

-94.21%

10年

-98.72%

關於： MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. The company offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future and HC Securities, and MM Global. The Gujia segment provides market data services and consulting services to customers in China; and MM Global segment operates as an introducing broker that clears all transactions through a clearing broker dealer and earns commission income.

員工： 31

金融資本市場

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 0%

負面 100%

MMTec: Now We've Even Seen A 100% Revenue Drop

MMTec, Inc. reported a 100% drop in sales, with revenues falling from $807.5k to zero year-over-year. MTC's market cap exceeds $300 million despite having under $13 million in common equity and no revenue, raising major red flags. Massive dilution occurred, with shares outstanding rising from 25.19 million to 99.59 million, and further dilution is likely.

MMTec: Now We've Even Seen A 100% Revenue Drop

Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform

BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule drugs. The research marks a significant demonstration of how combinatorial NAMs en.

Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform

MMTEC, Inc. Announces Receipt of Nasdaq Decision Regarding Minimum Bid Price Deficiency

HONG KONG , Dec. 11, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on December 9, 2025, the Company received a decision letter (the "Decision Letter") from the Nasdaq Hearings Panel of The Nasdaq Stock Market LLC ("Nasdaq"). The Company previously received a determination letter (the "Determination Letter") which advised that for the 30 consecutive business days prior to the date of the Determination Letter the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").

MMTEC, Inc. Announces Receipt of Nasdaq Decision Regarding Minimum Bid Price Deficiency

MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency

HONG KONG , Oct. 28, 2025 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on October 27, 2025, the Company received a determination letter (the "Determination Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding a failure to meet Nasdaq's minimum bid price requirements. The Determination Letter advised that for the last 30 consecutive business the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").

MMTEC, Inc. Announces Receipt of Nasdaq Delisting Determination Regarding Minimum Bid Price Deficiency

MMTEC, Inc. Announces 1-for-8 Reverse Stock Split

HONG KONG , Dec. 12, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC) reported that it expects to implement a 1-for-8 reverse stock split on its common stock. The effective date is scheduled to be December 18, 2024, subject to the Company's satisfaction of Nasdaq Operations notice requirements, with trading to begin on a split-adjusted basis at the market open on that day.

MMTEC, Inc. Announces 1-for-8 Reverse Stock Split

MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG , July 10, 2024 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), a China-based technology company that provides access to the U.S. financial markets, today announced that on July 8, 2024, the Company received a notification letter (the "Notification Letter") from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") regarding a failure to meet Nasdaq's minimum bid price requirements. The Notification Letter advised that for the last 30 consecutive business the minimum closing bid price per share for the Company's common stock was below the $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule").

MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS

HONG KONG , May 8, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC), announced that it will suspend the acceptance of new investments and pause the Company's capital raising activities for the next six months. In light of the Company's current capital position, combined with a comprehensive assessment of the current market environment and our business operations, our management team has decided to suspend the Company's financing plans for the next six months.

MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS

查看新聞排名

價格圖表採用Lightweight Charts™實作